The field of cancer theragnostics has long been starving for imaging agents with an improved targeting efficiency. Herein, a dual receptor targeting nanoprobe with fluorescence-SERS dual mode imaging capacity has been demonstrated for the specific targeting of cervical cancer cells. First, silver nanoparticles were modified with Raman reporters and silica-protected fluorescence dyes to incorporate fluorescence-SERS dual mode imaging capacity. Then, two targeting peptides, transferrin receptor-specific peptide T7 and integrin ανβ₃ bonding peptide RGD, were functionalized onto the outer surfaces of the nanoparticles, endowing the nanoprobes with enhanced recognition towards HeLa cells. Finally, to investigate the targeting capability of this synergetic probe, the cellular internalization was compared between single and dual targeting nanoprobes. The results from fluorescence-SERS dual-mode imaging demonstrated that the dual peptide functionalized nanoprobes not only promoted an elevated uptake by cancer cells, but were also responsible for an enhanced targeting ability towards cancer cells. This type of nanoprobe with dual-mode imaging and a dual-targeting ability would give a new prospect for the diagnosis and therapeutics of cancer.